Editorial Board
Marco Gambarotti
Rizzoli Orthopaedic Institute · Italy
Editorial leadership for Journal of Hematology and Oncology Research ISSN 2372-6601
Research interests
- Bone
- Soft Tissue Tumors; Bone
- Soft Tissue Diseases; Joint Diseases
Biography
- Degree in Medicine and Surgery, with honors.
- Specialization in Anatomic Pathology, with honors.
- Researcher at the University of Brescia from April 2007 to May 2008 (title of the project: "Evaluation and improvement about the pathologic activity in liver diseases").
- Since May 2008 pathologist in the Pathology Department of the Rizzoli Orthopaedic Institute in Bologna.
- He has diagnosed more than 15.000 cases of soft tissue and bone pathology.
- He worked under the direction of dr. Marco Alberghini until June 2012.
- He is working with the advice of Prof. Franco Bertoni,
- Dr. Angelo Paolo Dei Tos, dr. Piero Picci, and Prof. Daniel Vanel (consultant radiologist of the Rizzoli Orthopedic Institute).
- Teaching activities: educational training of Italian and foreign visitors who regularly visit the Pathology Department of the Rizzoli Orthopedic Institute; teacher of Anatomic Pathology at the School of Specialization in Rheumatology (University of Bologna).
- Author and co-author of 57 scientific papers on National or International Journals (H-index: 13; i10-index: 15).
- Co-author of the “Atlas of Musculoskeletal Tumors and Tumorlike Lesions - The Rizzoli Case Archive.
- Participation in many courses about Anatomic Pathology and Musculoskeletal Oncology.
- In particular he is co-organizator and speaker in the annual “Joint IOR/MSKCC Course on Musculoskeletal Pathology of the Rizzoli Orthopedic Institute.
- Member of the ISG (Italian Sarcoma Group), of the ISS (International Skeletal Society), and of the EMSOS (European Musculo-Skeletal Oncology Society).
Selected publications
- A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl) 2023 cited 39×
- Detection of circulating tumor cells in liquid biopsy from Ewing sarcoma patients 2018 cited 38×
- Genomics and Therapeutic Vulnerabilities of Primary Bone Tumors 2020 cited 32×
- Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study 2021 cited 31×
- The natural history of epithelioid sarcoma. A retrospective multicentre case-series within the Italian Sarcoma Group 2020 cited 21×
- Giant Cell Tumor of Bone in Patients under 16 Years Old: A Single-Institution Case Series 2021 cited 18×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JHOR for your work?
This journal is guided by Marco Gambarotti (Rizzoli Orthopaedic Institute) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.